SP3 and cancer: Increasing evidence has also shown that Sp1 and Sp3 are expressed at higher levels in a number of cancer cells than in normal cells, and knockdown of Sp1 or Sp3 in cancer cells dramatically reduced tumorigenic and metastatic phenotypes (50).